Standout Papers
Immediate Impact
55 standout
Citing Papers
A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
2025 Standout
Thirty years of NRF2: advances and therapeutic challenges
2025 Standout
Works of Kavitha Ramchandran being referenced
Role of KEAP1/NFE2L2 Mutations in the Chemotherapeutic Response of Patients with Non–Small Cell Lung Cancer
2019
Impact of KEAP1/NFE2L2/CUL3 mutations on duration of response to EGFR tyrosine kinase inhibitors in EGFR mutated non-small cell lung cancer
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Kavitha Ramchandran | 410 | 270 | 331 | 69 | 933 | |
| Fabrizio Artioli | 441 | 174 | 310 | 48 | 880 | |
| Janise M. Roh | 694 | 145 | 138 | 76 | 1.1k | |
| Susan C. Gilchrist | 514 | 130 | 190 | 44 | 1.2k | |
| Raquel E. Reinbolt | 565 | 120 | 202 | 56 | 1.0k | |
| Michael J. Messino | 466 | 144 | 210 | 33 | 925 | |
| G. J. van Londen | 432 | 124 | 180 | 44 | 806 | |
| Weiva Sieh | 294 | 148 | 253 | 53 | 1.0k | |
| Paolo Tralongo | 529 | 99 | 237 | 49 | 948 | |
| Anne M. May | 500 | 146 | 139 | 45 | 818 | |
| Nadia Obi | 497 | 136 | 110 | 61 | 996 |
All Works
Login with ORCID to disown or claim papers
Loading papers...